SCHEMBL4434733

SCHEMBL4434733

CC(C=O)(OC(N)=O)c1cccc(Br)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ PARP1 P09874 1/20 0.40
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA5A P35218 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ PKM P14618 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ MAPT P10636 1/20 0.34
▸ HSD17B3 P37058 1/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ C1S P09871 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18039529 0.83 RAB9A (0.38) SMN1; SMN2KMT2AMEN1CA1CA2
SCHEMBL2171913 0.82 NPC1 (0.41) SMN1; SMN2KMT2AMEN1CA1CA2
SCHEMBL28039485 0.77 PARP1 (0.40) SMN1; SMN2KMT2AMEN1PARP1CA1
SCHEMBL27808388 0.75 PARP1 (0.39) SMN1; SMN2KMT2AMEN1PARP1CA1
SCHEMBL16056375 0.73 KMT2A (0.60) SMN1; SMN2KMT2AMEN1PARP1CA1
SCHEMBL27893711 0.72 PARP1 (0.36) SMN1; SMN2KMT2AMEN1PARP1CA1
SCHEMBL27893710 0.72 PARP1 (0.36) SMN1; SMN2KMT2AMEN1PARP1CA1
SCHEMBL29700890 0.72 ALDH1A1 (0.45) SMN1; SMN2KMT2AMEN1PARP1CA1
SCHEMBL16774281 0.72 ALDH1A1 (0.45) SMN1; SMN2KMT2AMEN1PARP1CA1
SCHEMBL4477529 0.72 KCNN4 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103097389-B 4, 7-dihydro-pyrazolo [1,5-a ] pyrazin-6-ylamine derivatives as inhibitors of beta-secretase (BACE) JANSSEN PHARMACEUTICA N.V. (BE) 2015-10-14 — — CN disclosed
EP-2097387-A2 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2009-09-09 — — EP disclosed
WO-2008103351-A2 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2008-08-28 — — WO disclosed
EP-1838304-A2 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2007-10-03 — — EP disclosed
WO-2006065277-A2 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2006-06-22 — — WO disclosed
Send feedback